Crystal structures of 3-(2H-1,3-benzodioxol-5-ylmethyl)-2-(m- and p-nitrophenyl)-1,3-thiazolidin-4-ones: different roles of the oxygen atoms
Author:
Facchinetti Victor1, Gomes Claudia R.B.1, Cunico Wilson2, Wardell Solange M.S.V.3, Wardell James L.
Affiliation:
1. Fundação Oswaldo Cruz, Instituto de Tecnologia em Fármacos-Far Manguinhos, Manguinhos, 21041-250, Rio de Janeiro, Brazil 2. Departamento de Química Orgânica, Universidade Federal de Pelotas (UFPel), Campus Universitário, s/n, Caixa Postal 354, 96010-900 Pelotas, RS, Brazil 3. CHEMSOL, 1 Harcourt Road, Aberdeen AB15 5NY, Scotland
Abstract
Abstract
The crystal structures of two isomeric 3-(2H-1,3-benzodioxol-5-ylmethyl)-2-(aryl)-1,3-thiazolidin-4-one compounds (1: aryl=4-O2NC6H4; 2: aryl=3-O2NC6H4) are reported. In both these nonplanar, compounds, the carbonyl oxygen is involved in intramolecular C–H···O hydrogen bonds. However, there are significant differences in the sets of intermolecular interactions, in particular the roles of the oxygen atoms, exhibited by the two compounds. Thus in 1, a dioxolyl oxygen and the two nitro group oxygen atoms are each involved in different chain forming C–H···O intermolecular hydrogen bonds, while the carbonyl oxygen atom is not involved in any intermolecular interaction. In 2, the dioxolyl oxygen atom is involved in the formation of centrosymmetric dimers, the carbonyl oxygen in three different C–H···O hydrogen bonds and the nitro group oxygens in two N–O···π(aryl) interactions. Compound 2 exhibits also C–H···π(phenyl), π(phenyl)···π(phenyl) and π(benzodioxolyl)···π(benzodioxolyl) interactions, while in 1 only the latter interaction is present. Compound 1 crystallizes in the monoclinic space group, P21/a with Z=4, while compound 2 crystallizes in the triclinic space group, P1̅, with Z=2.
Publisher
Walter de Gruyter GmbH
Subject
Inorganic Chemistry,Condensed Matter Physics,General Materials Science
Reference35 articles.
1. C. Tripathi, S. J. Gupta, G. N. Fatima, P. K. Sonar, A. Verma, S. K. Saraf, 4-Thiazolidinones: the advances continue… Eur. J. Med. Chem.2014, 72, 52. 2. V. R. Solomon, W. Haq, K. Srivastava, S. K. Puri, S. B. Katti, Synthesis and antimalarial activity of side chain modified 4-aminoquinoline derivatives. J. Med. Chem.2007, 50, 394. 3. E. Pitta, E. Tsolaki, A. Geronikaki, J. Petrović, J. Glamočlija, M. Soković, E. Crespan, G. Maga, S. S. Bhunia, A. K. Saxena, Thiazolidinone derivatives as potent antimicrobial agents: microwave-assisted synthesis, biological evaluation and docking studies. Mend. Comm.2015, 6, 319. 4. G. H. Marques, A. Kunzler, V. D. O. Bareno, B. B. Drawanz, H. G. Maetelloto, F. R. M. Leite, G. G. Nascimento, P. S. Nascente, G. M. Siqueira, W. Cunico, Antifungal activity of 3-(heteroaryl-2-ylmethyl)thiazolidinone derivatives. Med. Chem. (Hilversum)2014, 10, 355. 5. V. Ravichandran, B. R. Prashantha Kumar, S. Sankar, R. K. Agrawal, Predicting anti-HIV activity of 1,3,4-thiazolidinone derivatives: 3D-QSAR approach. Eur. J. Med. Chem.2009, 44, 1180.
|
|